Treatment guidelines in polycythemia vera currently recommend maintaining hematocrit below 45%, with a higher threshold for men vs women. Treatment guidelines in PV currently recommend maintaining ...

Hematocrit is the percentage of red blood cells in a person‘s blood. A typical hematocrit range in adults is 36–54%. However, age, sex, and health conditions can influence hematocrit levels. Low red ...

Anemia affects more than 1 in 4 pregnant individuals in the US, with prevalence increasing from prenatal care initiation to ...

SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed. The ...

ATLANTA -- Maintaining patients with polycythemia vera at hematocrit levels below 45% reduced thrombotic complications without increasing rates of other serious adverse events compared with a higher ...

What Does a Hematocrit Test Measure? A hematocrit test is a blood test that measures the level of red blood cells in your blood. Your blood is made up of plasma and blood cells. Plasma is the liquid ...

Providence, RI - In a new study, even mild degrees of preoperative anemia or polycythemia (high red blood cell count) were associated with an increased risk of 30-day postoperative mortality and ...

The data and safety monitoring committee recommended termination of the study after 29 months (median duration of treatment, 14 months). The committee was convened on June 3, 1996, and reviewed data ...

THE measurement of the packed red-cell volume (or hematocrit) of the venous blood has long been recognized as a useful aid in the study of blood in a large number of clinical conditions. The technic ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — The standard approach of maintaining hematocrit levels less than 45% in patients with polycythemia ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...